Voelker, Linus A.; Kaufeld, Jessica; Miesbach, Wolfgang et al.
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraBLOOD ADVANCES. Bd. 4. H. 13. 2020 S. 3085-3092
Korn, Stephanie; Buhl, Roland
Reply to the Letter Entitled "FeNO Variability when Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff"RESPIRATION. Bd. 99. H. 1. 2020 S. 94-94
Fuerstenau, M.; Bahlo, J.; Fink, A. M. et al.
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemiaLEUKEMIA. Bd. 34. H. 3. 2020 S. 924-928
Virchow, J. Christian; McDonald, Mirna; Garin, Margaret et al.
Reslizumab as add-on therapy in patients with refractory asthmaBMJ OPEN RESPIRATORY RESEARCH. Bd. 7. H. 1. 2020
Pavord, Ian D.; Bleecker, Eugene R.; Buhl, Roland et al.
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsERJ OPEN RESEARCH. Bd. 6. H. 3. 2020
Goldschmidt, Hartmut; Mai, Elias K.; Duerig, Jan et al.
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialLEUKEMIA. 2020
Rashid, Humayra; Eichler, Martin; Hechtner, Marlene et al.
Returning to work in lung cancer survivors-a multi-center cross-sectional study in GermanySUPPORTIVE CARE IN CANCER. 2020
Zeiser, Robert; von Bubnoff, Nikolas; Butler, Jason et al.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseNEW ENGLAND JOURNAL OF MEDICINE. Bd. 382. H. 19. 2020 S. 1800-1810
Beck, Olaf; Paret, Claudia; Russo, Alexandra et al.
Safety and Activity of the Combination of Ceritinib and Dasatinib in OsteosarcomaCANCERS. Bd. 12. H. 4. 2020
Jackson, David J.; Korn, Stephanie; Mathur, Sameer K. et al.
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on BenralizumabDRUG SAFETY. Bd. 43. H. 5. 2020 S. 409-425